Bivalirudin PCI Registry in HIT/HITTS Patients.

Trial Profile

Bivalirudin PCI Registry in HIT/HITTS Patients.

Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2011

At a glance

  • Drugs Bivalirudin (Primary)
  • Indications Embolism and thrombosis; Heparin-induced thrombocytopenia and thrombosis syndrome
  • Focus Therapeutic Use
  • Sponsors The Medicines Company
  • Most Recent Events

    • 09 Nov 2011 Status changed from recruiting to completed as reported by
    • 08 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top